Vanderbilt's Michael Dewan, MD, MSCI, has received a grant from the Pediatric Brain Tumor Foundation to study why some low-grade gliomas, a type of non-cancerous brain or spine tumor, spread and behave like cancerous tumors.

Fewer Black, Hispanic and Asian patients meet biomarker qualifications for landmark treatments that may slow the progression of Alzheimer’s disease by targeting amyloid plaques, according to new findings published in JAMA Neurology.

Herbert Christopher, a grateful Otolaryngology–Head and Neck Surgery patient who received cochlear hearing implants from David Haynes, MD, has funded the training of otolaryngology fellows and leaders in Alzheimer’s disease care through several outright endowed gifts and additional gift planning with his estate.

The Today Show’s Maria Shriver spotlighted a landmark, years-long study into the connection between heart health and Alzheimer’s disease, and the urgency to boost study enrollment—particularly among people of color who are disproportionally impacted yet historically underrepresented in research.

Specializing in dementia and Alzheimer’s disease, neurologist Aaron McMurtray, MD, PhD, recently joined Vanderbilt University Medical Center as associate professor of Neurology.

Vanderbilt's Lucie Kalousová, PhD, and Corey Bolton, PsyD, have received research awards from the Alzheimer’s Association.

The third annual Vanderbilt Alzheimer’s Disease Research Day featured numerous presentations and concluded with a keynote address by Suzanne Craft, PhD, director of the Alzheimer’s Disease Research Center at Wake Forest University.